Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis (Q44382397)

2 December 2017

title

Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis (English)

1 reference

2 December 2017

0 references

1 reference

Seho Park

1

1 reference

2 December 2017

Ji Min Park

2

1 reference

2 December 2017

Jung Hoon Cho

3

1 reference

2 December 2017

Hyung Seok Park

4

1 reference

2 December 2017

Seung Il Kim

5

1 reference

2 December 2017

Byeong-Woo Park

6

1 reference

2 December 2017

publication date

5 May 2013

1 reference

Annals of Surgical Oncology

2 December 2017

published in

1 reference

2 December 2017

volume

20

1 reference

2 December 2017

issue

9

1 reference

2 December 2017

page(s)

2858-2865

1 reference

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

Recent advances in systemic therapy: advances in neoadjuvant (primary) systemic therapy with cytotoxic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

The evolution of the locoregional therapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

How many sentinel lymph nodes are enough for accurate axillary staging in t1-2 breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

Surgical considerations in patients receiving neoadjuvant systemic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

Neoadjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-2992-8

10.1245/S10434-013-2992-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

2 December 2017

1018055536

0 references

Fatcat ID

release_skrg4xgrbvdwjbtxb7tcdx2hju

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/skrg4xgrbvdwjbtxb7tcdx2hju

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference